Compare PBLS & QLYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PBLS | QLYS |
|---|---|---|
| Founded | N/A | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.6B | 3.2B |
| IPO Year | 2026 | 2012 |
| Metric | PBLS | QLYS |
|---|---|---|
| Price | $30.76 | $136.52 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 13 |
| Target Price | N/A | ★ $133.08 |
| AVG Volume (30 Days) | 502.7K | ★ 828.0K |
| Earning Date | N/A | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 16.99 |
| EPS | N/A | ★ 1.42 |
| Revenue | N/A | ★ $321,607,000.00 |
| Revenue This Year | N/A | $9.97 |
| Revenue Next Year | N/A | $7.15 |
| P/E Ratio | ★ N/A | $94.18 |
| Revenue Growth | N/A | ★ 15.32 |
| 52 Week Low | $25.56 | $74.51 |
| 52 Week High | $33.65 | $167.86 |
| Indicator | PBLS | QLYS |
|---|---|---|
| Relative Strength Index (RSI) | 56.52 | 48.06 |
| Support Level | $26.83 | $136.17 |
| Resistance Level | $33.65 | $154.54 |
| Average True Range (ATR) | 2.62 | 8.78 |
| MACD | 0.14 | -3.90 |
| Stochastic Oscillator | 63.76 | 13.71 |
Parabilis Medicines Inc s a clinical-stage biopharmaceutical company. It is focused on the development of medicines targeting protein interactions associated with human diseases. It uses a proprietary platform to develop stabilized helical peptide therapeutics, referred to as Helicons, designed to bind and modulate specific proteins. Its flagship product candidate, zolucatetide, targets the interaction between β-catenin and the T-cell factor (TCF) family of transcription factors within the Wnt/β-catenin signaling pathway, which is associated with cell proliferation and differentiation in multiple cancer types.
Qualys is a cloud security and compliance solutions provider that helps businesses identify and manage their security risks and compliance requirements. The California-based company has more than 10,000 customers worldwide, the majority of which are small- and medium-size businesses. Qualys was founded in 1999 and went public in 2012.